ARCHIVES

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

March 23, 2007

NCI “Can’t Justify Size Of Intramural Program”

May 12, 1995

National Action Plan: Return $14 Million To NCI, Committee Tells Shalala

February 14, 1997

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

September 27, 2013

NCI Cooperative Group Clinical Trials Listed

April 24, 2009

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009